Evidence map›Paper›PMID 30540948›Full record

ArticleCell reports2018

Importin α5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1.

Nicolas Panayotis, Anton Sheinin, Shachar Y Dagan, Michael M Tsoory, Franziska Rother, Mayur Vadhvani, Anna Meshcheriakova, Sandip Koley, Letizia Marvaldi, Didi-Andreas Song and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Nuclear transport proteins: structure, function, and disease relevance.Signal transduction and targeted therapy · 2023
    Review
  7. Glial Sphingosine-Mediated Epigenetic Regulation Stabilizes Synaptic Function inThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  8. Article
  9. State-of-the-art therapies for Rett syndrome.Developmental medicine and child neurology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Nicolas PanayotisDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Anton SheininSagol School of Neuroscience, Tel Aviv University, Tel Aviv 69978, Israel.
Shachar Y DaganDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Michael M TsooryDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot 76100, Israel.
Franziska RotherMax-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany; Center for Structural and Cellular Biology in Medicine, Institute of Biology, University of Lübeck, 23538 Lübeck, Germany.
Mayur VadhvaniInstitute of Biochemistry, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Anna MeshcheriakovaDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Sandip KoleyDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Letizia MarvaldiDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Didi-Andreas SongDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Eitan ReuvenyDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel.
Britta J EickholtInstitute of Biochemistry, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Enno HartmannMax-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany; Center for Structural and Cellular Biology in Medicine, Institute of Biology, University of Lübeck, 23538 Lübeck, Germany.
Michael BaderMax-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany; Center for Structural and Cellular Biology in Medicine, Institute of Biology, University of Lübeck, 23538 Lübeck, Germany.
Izhak MichaelevskiDepartment of Molecular Biology, Integrative Brain Research Center - Ariel, Ariel University, Ariel 40700, Israel.
Mike FainzilberDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: mike.fainzilber@weizmann.ac.il.
Weizmann Institute of Science · ILCharité - Universitätsmedizin Berlin · DEUniversity of Lübeck · DEAriel University · ILMax Delbrück Center · DETel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importins mediate transport from synapse to soma and from cytoplasm to nucleus, suggesting that perturbation of importin-dependent pathways should have significant neuronal consequences. A behavioral screen on five importin α knockout lines revealed that reduced expression of importin α5 (KPNA1) in hippocampal neurons specifically decreases anxiety in mice. Re-expression of importin α5 in ventral hippocampus of knockout animals increased anxiety behaviors to wild-type levels. Hippocampal neurons lacking importin α5 reveal changes in presynaptic plasticity and modified expression of MeCP2-regulated genes, including sphingosine kinase 1 (Sphk1). Knockout of importin α5, but not importin α3 or α4, reduces MeCP2 nuclear localization in hippocampal neurons. A Sphk1 blocker reverses anxiolysis in the importin α5 knockout mouse, while pharmacological activation of sphingosine signaling has robust anxiolytic effects in wild-type animals. Thus, importin α5 influences sphingosine-sensitive anxiety pathways by regulating MeCP2 nuclear import in hippocampal neurons.

Indexed as

alpha KaryopherinsAnimalsAnti-Anxiety AgentsAnxietyBehavior, AnimalCarbolinesHippocampusMethyl-CpG-Binding Protein 2Mice, KnockoutNeuronsPhenotypePhosphotransferases (Alcohol Group Acceptor)Sphingosine KinaseSynapsesTranscription, Geneticalpha KaryopherinsAnti-Anxiety AgentsCarbolinesFG 7142KPNA1 protein, mouseMethyl-CpG-Binding Protein 2Phosphotransferases (Alcohol Group Acceptor)Sphingosine KinaseanxietyanxiolyticimportinkaryopherinKPNA1MeCP2sphingosine kinasesynapse-nucleus communication

Identifiers

PMID30540948
PMCPMC6302549
OpenAlexW2904679003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.